![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Prostate Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Editorial Comment: Time to Ditch Bone Scans for Prostate Cancer Workup in the Era
of PSMA PET/CT?
AJR Am J Roentgenol. 2022 Jun 29:11. doi: 10.2214/AJR.22.27867.
PubMed
Exercise Training to Increase Tumor NK Cell Infiltration in Men with Localized
Prostate Cancer: an RCT.
BJU Int. 2022 Jun 26. doi: 10.1111/bju.15842.
PubMed
Abstract available
FDA approves new agent for the treatment of metastatic prostate cancer.
BJU Int. 2022;130:3-4.
PubMed
Sensible government decisions on funding for imaging can change practice and
deliver better care for men with prostate cancer.
BJU Int. 2022;130 Suppl 1:4.
PubMed
Correction to: Robot-assisted radical prostatectomy in the treatment of patients
with clinically high-risk localized and locally advanced prostate cancer: single
surgeons functional and oncologic outcomes.
BMC Urol. 2022;22:92.
PubMed
Changes in prostate cancer survival among insured patients in relation to USPSTF
screening recommendations.
BMC Urol. 2022;22:91.
PubMed
Abstract available
Squalene epoxidase metabolic dependency is a targetable vulnerability in
castration-resistant prostate cancer.
Cancer Res. 2022 Jun 29. pii: 705311. doi: 10.1158/0008-5472.CAN-21-3822.
PubMed
Abstract available
Identification of hub genes predicting the development of prostate cancer from
benign prostate hyperplasia and analyzing their clinical value in prostate cancer
by bioinformatic analysis.
Discov Oncol. 2022;13:54.
PubMed
Abstract available
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients:
Results from a Multicenter Series.
Eur Urol. 2022 Jun 21. pii: S0302-2838(22)02400.
PubMed
Abstract available
Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate
Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib:
Results from TALAPRO-1.
Eur Urol. 2022 Jun 21. pii: S0302-2838(22)02407.
PubMed
Abstract available
Prostate-specific antigen (PSA) and biopsy contamination in the Goteborg-1
randomized, population-based, prostate cancer screening trial.
J Urol. 2022 Jun 30:101097JU0000000000002835. doi: 10.1097/JU.0000000000002835.
PubMed
Abstract available
Urological Oncology: Prostate Cancer.
J Urol. 2022 Jun 27:101097JU0000000000002796. doi: 10.1097/JU.0000000000002796.
PubMed
Feasibility of accelerated whole-body diffusion-weighted imaging using a deep
learning-based noise-reduction technique in patients with prostate cancer.
Magn Reson Imaging. 2022 Jun 27. pii: S0730-725X(22)00108.
PubMed
Abstract available
The link between vitamin D and prostate cancer.
Nat Rev Cancer. 2022 Jun 27. pii: 10.1038/s41568-022-00493.
PubMed
Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced
prostate cancer.
Oncogene. 2022 Jun 27. pii: 10.1038/s41388-022-02382.
PubMed
Abstract available
Conventional androgen deprivation therapy is associated with an increased risk of
cardiovascular disease in advanced prostate cancer, a nationwide population-based
study.
PLoS One. 2022;17:e0270292.
PubMed
Abstract available
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate
cancer.
Proc Natl Acad Sci U S A. 2022;119:e2203820119.
PubMed
Abstract available
Elevated serum CEA is associated with liver metastasis and distinctive
circulating tumor DNA alterations in patients with castration-resistant prostate
cancer.
Prostate. 2022 Jun 29. doi: 10.1002/pros.24400.
PubMed
Abstract available
Gene variation impact on prostate cancer progression: Lymphocyte modulator,
activation, and cell adhesion gene variant contribution.
Prostate. 2022 Jun 29. doi: 10.1002/pros.24407.
PubMed
Abstract available
Does castration status affect docetaxel-related adverse events? :Identification
of risk factors for docetaxel-related adverse events in metastatic prostate
cancer.
Prostate. 2022 Jun 29. doi: 10.1002/pros.24406.
PubMed
Abstract available
Role of molecular imaging in the detection of localized prostate cancer.
Ther Adv Urol. 2022;14:17562872221105018.
PubMed
Abstract available
Two Specialists, Two Recommendations: Discordance between Urologists' & Radiation
Oncologists' Prostate Cancer Treatment Recommendations.
Urology. 2022 Jun 26. pii: S0090-4295(22)00512.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by